T-705RTP is a selective and GTP-competitive inhibitor of influenza virus RNA polymerase (IC₅₀ = 0.14 μM, Kᵢ = 1.52 μM), serving as the active triphosphate metabolite of favipiravir (T-705) with potent anti-influenza viral activity; it inhibits influenza virus RNA polymerase activity in a dose-dependent and GTP-competitive manner, suppresses the incorporation of ATP and GTP competitively (Kᵢ = 7.72 and 1.56 μM, respectively), inhibits CTP incorporation in a mixed-type manner (Kᵢ = 11.3 μM), and noncompetitively inhibits UTP incorporation; a single molecule of T-705RTP (10–1000 μM) is sufficient to block influenza virus RNA strand elongation.